Publication: Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies
| dc.contributor.author | KAYMAKÇIOĞLU, BEDİA | |
| dc.contributor.author | TOK, FATİH | |
| dc.contributor.authors | Tok, Fatih; Ugras, Zefine; Saglik, Begum Nurpelin; Ozkay, Yusuf; Kaplancikli, Zafer Asim; Kocyigit-Kaymakcioglu, Bedia | |
| dc.date.accessioned | 2022-03-12T22:55:44Z | |
| dc.date.accessioned | 2026-01-10T19:43:18Z | |
| dc.date.available | 2022-03-12T22:55:44Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Thirty novel 2,5-disubstituted-1,3,4-oxadiazole derivatives bearing urea moiety were designed and synthesized. IR, 1H-NMR, 13C-NMR and mass spectroscopic methods and elemental analysis were used to confirm the structures of the compounds. Their monoamine oxidase inhibitory activity was determined against the MAO-A and MAO-B isoforms. None of the compounds showed the potent MAO-A inhibitory activity, while the MAO-B inhibition was significantly found in the range of 62 to 98%. Among them, the compounds H8, H9 and H12 bearing chloro substituent at the fourth position of phenylurea were found to show potent monoamine oxidase B inhibitory activity with IC50 values 0.039-0.066 mu M. To define and evaluate the interaction mechanism between compound H8 and monoamine oxidase B, molecular docking studies have been made. | |
| dc.identifier.doi | 10.1016/j.bioorg.2021.104917 | |
| dc.identifier.eissn | 1090-2120 | |
| dc.identifier.issn | 0045-2068 | |
| dc.identifier.pubmed | 33932769 | |
| dc.identifier.uri | https://hdl.handle.net/11424/236818 | |
| dc.identifier.wos | WOS:000661870300006 | |
| dc.language.iso | eng | |
| dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | |
| dc.relation.ispartof | BIOORGANIC CHEMISTRY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | MAO inhibitors | |
| dc.subject | 1 | |
| dc.subject | 3 | |
| dc.subject | 4-oxadiazole | |
| dc.subject | Molecular docking | |
| dc.subject | Urea derivatives | |
| dc.subject | IN-SILICO EVALUATION | |
| dc.subject | DESIGN | |
| dc.subject | VITRO | |
| dc.subject | 1,3,4-OXADIAZOLE | |
| dc.subject | COMPLEXES | |
| dc.subject | HYDRAZONE | |
| dc.subject | DOCKING | |
| dc.subject | MOIETY | |
| dc.title | Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | BIOORGANIC CHEMISTRY | |
| oaire.citation.volume | 112 |
